Biotech Snap

Investor Due Diligence Report

by Joachim Eeckhout

beehiivHealth

A daily 5-min biotech briefing

View full profile →Download PDF

Key Metrics

Subscribers

Low confidence

Weekly Growth

~0%

Subscriber count is a platform estimate

Quality & Publishing

Audience Quality Score

52Fair

0100

Publishing Pace

Daily

7.7 posts/week

Publishing Consistency

82/100

Very Consistent (~1.7d avg)

Component	Score	Weight
Publishing Consistency	70/100	10%

Competitive Landscape (Health)

Newsletter	Subscribers	Weekly Growth	Price	Platform
The Forgotten Side of Medicine	343K	+0.3%	$7/mo	substack
Neuroscience & Wellness	241K	+4.5%	$7.99/mo	substack
Nedra Nuggets	151K	-0.3%	$6.99/mo	substack
COVID Intel - by William Makis (McGill Medicine)	142K	N/A	$7.5/mo	substack

Risk Assessment

Key risk factors for due diligence

Medium

Platform Dependency

Uses beehiiv platform

Low

Publishing Consistency

Regular publishing schedule

Medium

Key Person

Single-author publication — key-person dependency

High

Revenue Model

Pre-monetization — no paid subscription tier

Monetization Readiness

Readiness for paid subscriptions

Subscriber threshold

1K subscribers — below the 2K category median (based on 598 newsletters)

Has paid tier

No paid subscription tier yet

Peer monetization

100% of 366 similar-size peers in Health have paid tiers

Data Quality

Report Data QualityLimited - Key metrics unavailable

Subscriber Confidencelow

Disclaimer: This report is generated automatically based on publicly available data and proprietary estimation models. Estimated subscriber counts are derived from engagement patterns and should be verified through direct disclosure. Revenue estimates are based on known pricing and estimated paid subscriber counts. This report is for informational purposes only and should not be the sole basis for investment decisions.